Stuart A Arbuckle's Net Worth

$141 Million

Estimate Recalculated May 17, 2026 07:03AM EST

Who is Stuart A Arbuckle

Stuart A Arbuckle has an estimated net worth of $141 Million. This is based on reported shares across multiple companies, which include RHYTHM PHARMACEUTICALS, INC., VERTEX PHARMACEUTICALS INC / MA, ImmunoGen, Inc., and Cerulean Pharma Inc..

SEC CIK

Stuart A Arbuckle's CIK is 0001557290

Past Insider Trading and Trends

2018 was Stuart A Arbuckle's most active year for acquiring shares with 33 total transactions. Stuart A Arbuckle's most active month to acquire stocks was the month of January. 2020 was Stuart A Arbuckle's most active year for disposing of shares, totalling 69 transactions. Stuart A Arbuckle's most active month to dispose stocks was the month of January. 2017 saw Stuart A Arbuckle paying a total of $18,014,321.38 for 258,022 shares, this is the most they've acquired in one year. In 2017 Stuart A Arbuckle cashed out on 509,204 shares for a total of $43,332,934.78, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

RHYTHM PHARMACEUTICALS, INC.

Investor
Updated Jun 26, 2025
11.75KJun 24
7.00KJun 18
3.00KJun 21
18.00KJun 18
17.00KJun 21
20.00KJun 08
15.00KJun 09
18.50KJun 17
30.00KJul 30
Showing 10 results

VERTEX PHARMACEUTICALS INC / MA

EVP, COO
Updated Jul 02, 2025
Jul 01
100.75KMay 13
Feb 26
Feb 24
Feb 14
77.59KFeb 12
Feb 10
72.90KFeb 04
ScheduledMay 15
ScheduledFeb 23 - Feb 26
ScheduledFeb 21
ScheduledFeb 16 - Feb 20
ScheduledFeb 09 - Feb 12
83.33KFeb 06 - Feb 07
ScheduledDec 13
Jun 15
May 30
ScheduledFeb 24 - Feb 27
ScheduledFeb 22
ScheduledFeb 17 - Feb 21
ScheduledFeb 14
ScheduledFeb 10 - Feb 13
96.39KFeb 01
58.17KDec 06
ScheduledAug 15
ScheduledAug 10
ScheduledAug 09
ScheduledMay 16
ScheduledMay 02
Feb 24
Feb 17
Feb 10
79.62KFeb 01
ScheduledNov 15
ScheduledMay 17
ScheduledFeb 24 - Feb 25
ScheduledFeb 17 - Feb 18
ScheduledFeb 11
Feb 10
ScheduledFeb 03
ScheduledNov 16
ScheduledNov 03
ScheduledAug 03
ScheduledJul 07
ScheduledMay 15
ScheduledMay 04
ScheduledFeb 24 - Feb 25
ScheduledFeb 17 - Feb 18
ScheduledFeb 10 - Feb 11
ScheduledFeb 05 - Feb 06
ScheduledJan 31 - Feb 03
ScheduledNov 15
ScheduledNov 13
ScheduledNov 04
6.83%ScheduledAug 08
ScheduledAug 02 - Aug 05
ScheduledJun 19
ScheduledMay 15
ScheduledMay 02 - May 03
ScheduledApr 15
ScheduledFeb 11
97.10KFeb 06
ScheduledFeb 04
ScheduledJan 22
ScheduledNov 15
ScheduledNov 07
ScheduledNov 05
ScheduledNov 02
ScheduledAug 02 - Aug 03
ScheduledJul 13 - Jul 16
ScheduledJun 29
ScheduledJun 22
ScheduledMay 15
ScheduledApr 16
ScheduledFeb 26
ScheduledFeb 13
ScheduledFeb 12
82.23KFeb 06
ScheduledFeb 05
ScheduledFeb 02
ScheduledJan 24
ScheduledJan 16
ScheduledJan 11
Form 4/AScheduledNov 15
ScheduledNov 15
ScheduledNov 06
ScheduledOct 27 - Oct 31
ScheduledAug 07
ScheduledAug 03
ScheduledJul 31
ScheduledJul 19 - Jul 21
ScheduledJun 01 - Jun 02
ScheduledApr 28
ScheduledFeb 13
Feb 03
ScheduledNov 09
ScheduledOct 03
115.91KMay 25
ScheduledFeb 02 - Feb 03
ScheduledDec 04
ScheduledNov 16
ScheduledNov 05
ScheduledOct 30
ScheduledOct 01
ScheduledSep 04
ScheduledAug 05
34.00KJul 21
ScheduledMay 15
ScheduledApr 27
Feb 03
ScheduledNov 05
Oct 30
ScheduledOct 01
ScheduledSep 19
34.00KJul 15
Feb 05
ScheduledDec 12
ScheduledOct 01
34.00KJul 30
ScheduledJul 29
Feb 05
Sep 04
Showing 123 results

ImmunoGen, Inc.

Investor
Updated Feb 12, 2024
Feb 12
Dec 29
Sep 29
Jun 30
32.69KJun 14
Mar 31
107.00KJun 15
92.00KJun 16
83.00KJun 17
34.00KJun 20
45.80KJun 20
Showing 12 results

Cerulean Pharma Inc.

Investor
Updated Jan 05, 2017
Jan 03
Oct 03
20.00KJun 22
22.00KJun 26
Showing 5 results